| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1559 |
| 1 | METHOTREXATE SODIUM | 1482 |
| 2 | ETANERCEPT | 1448 |
| 3 | METHOTREXATE | 1350 |
| 4 | RITUXIMAB | 1327 |
| 5 | SECUKINUMAB | 1315 |
| 6 | LEFLUNOMIDE | 1304 |
| 7 | PREDNISONE | 1265 |
| 8 | DICLOFENAC SODIUM | 1216 |
| 9 | DICLOFENAC | 1174 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NICOTINAMIDE | 257 | 0.1006 |
| 1 | AZATHIOPRINE SODIUM | 241 | 0.0950 |
| 2 | GOLD | 531 | 0.0914 |
| 3 | HYDROCORTISONE BUTYRATE | 176 | 0.0891 |
| 4 | GOLIMUMAB | 1065 | 0.0846 |
| 5 | TALQUETAMAB-TGVS | 95 | 0.0638 |
| 6 | PSEUDOEPHEDRINE HCL | 603 | 0.0551 |
| 7 | CORTISONE ACETATE | 687 | 0.0550 |
| 8 | DICLOFENAC POTASSIUM TABLETS | 436 | 0.0503 |
| 9 | BOTULINUM TOXIN TYPE A | 628 | 0.0491 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1926 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1860 |
| 2 | Corticosteroid [EPC] | 1734 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1362 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1361 |
| 5 | Interleukin-17A Antagonist [EPC] | 1332 |
| 6 | Antirheumatic Agent [EPC] | 1305 |
| 7 | Vitamin C [EPC] | 1261 |
| 8 | Kinase Inhibitor [EPC] | 1227 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 1178 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 658 | 0.9564 |
| 1 | Interleukin-17A Antagonist [EPC] | 1332 | 0.0357 |
| 2 | Provitamin D2 Compound [EPC] | 855 | 0.0287 |
| 3 | Endoglycosidase [EPC] | 32 | 0.0173 |
| 4 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 87 | 0.0146 |
| 5 | Antirheumatic Agent [EPC] | 1305 | 0.0123 |
| 6 | beta3-Adrenergic Agonist [EPC] | 570 | 0.0119 |
| 7 | Aminosalicylate [EPC] | 1086 | 0.0108 |
| 8 | Human C1 Esterase Inhibitor [EPC] | 41 | 0.0105 |
| 9 | Antiseptic [EPC] | 46 | 0.0105 |